Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy (original) (raw)

References

  1. Zhang, L. et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N. Engl. J. Med. 348, 203–213 (2003).
    Article CAS Google Scholar
  2. Sato, E. et al. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc. Natl. Acad. Sci. USA 102, 18538–18543 (2005).
    Article CAS Google Scholar
  3. Hamanishi, J. et al. Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer. Proc. Natl. Acad. Sci. USA 104, 3360–3365 (2007).
    Article CAS Google Scholar
  4. Galon, J. et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313, 1960–1964 (2006).
    Article CAS Google Scholar
  5. Buckanovich, R.J. et al. Use of immuno-LCM to identify the in situ expression profile of cellular constituents of the tumor microenvironment. Cancer Biol. Ther. 5, 635–642 (2006).
    Article CAS Google Scholar
  6. Espina, V. et al. Laser-capture microdissection. Nat. Protoc. 1, 586–603 (2006).
    Article CAS Google Scholar
  7. Buckanovich, R.J. et al. Tumor vascular proteins as biomarkers in ovarian cancer. J. Clin. Oncol. 25, 852–861 (2007).
    Article CAS Google Scholar
  8. Levin, E.R. Endothelins as cardiovascular peptides. Am. J. Nephrol. 16, 246–251 (1996).
    Article CAS Google Scholar
  9. D'Orleans-Juste, P. et al. Function of the endothelin B receptor in cardiovascular physiology and pathophysiology. Pharmacol. Ther. 95, 221–238 (2002).
    Article CAS Google Scholar
  10. Bagnato, A., Spinella, F. & Rosano, L. Emerging role of the endothelin axis in ovarian tumor progression. Endocr. Relat. Cancer 12, 761–772 (2005).
    Article CAS Google Scholar
  11. Fukami, T. et al. Synthesis and structure-activity relationships of 2-substituted D-tryptophan–containing peptidic endothelin receptor antagonists: importance of the C-2 substituent of the D-tryptophan residue for endothelin A and B receptor subtype selectivity. J. Med. Chem. 39, 2313–2330 (1996).
    Article CAS Google Scholar
  12. Tsukahara, H., Ende, H., Magazine, H.I., Bahou, W.F. & Goligorsky, M.S. Molecular and functional characterization of the non–isopeptide-selective ETB receptor in endothelial cells. Receptor coupling to nitric oxide synthase. J. Biol. Chem. 269, 21778–21785 (1994).
    CAS PubMed Google Scholar
  13. Bouzin, C., Brouet, A., De Vriese, J., Dewever, J. & Feron, O. Effects of vascular endothelial growth factor on the lymphocyte-endothelium interactions: identification of caveolin-1 and nitric oxide as control points of endothelial cell anergy. J. Immunol. 178, 1505–1511 (2007).
    Article CAS Google Scholar
  14. Nelson, J., Bagnato, A., Battistini, B. & Nisen, P. The endothelin axis: emerging role in cancer. Nat. Rev. Cancer 3, 110–116 (2003).
    Article CAS Google Scholar
  15. Zhang, L. et al. Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma. Am. J. Pathol. 161, 2295–2309 (2002).
    Article CAS Google Scholar
  16. Courreges, M.C., Benencia, F., Conejo-Garcia, J.R., Zhang, L. & Coukos, G. Preparation of apoptotic tumor cells with replication-incompetent HSV augments the efficacy of dendritic cell vaccines. Cancer Gene Ther. 13, 182–193 (2006).
    Article CAS Google Scholar
  17. Peng, X., Treml, J. & Paterson, Y. Adjuvant properties of listeriolysin O protein in a DNA vaccination strategy. Cancer Immunol. Immunother. 56, 797–806 (2007).
    Article CAS Google Scholar
  18. Hodi, F.S. & Dranoff, G. Combinatorial cancer immunotherapy. Adv. Immunol. 90, 341–368 (2006).
    Article CAS Google Scholar
  19. Korman, A.J., Peggs, K.S. & Allison, J.P. Checkpoint blockade in cancer immunotherapy. Adv. Immunol. 90, 297–339 (2006).
    Article CAS Google Scholar
  20. Schlom, J., Arlen, P.M. & Gulley, J.L. Cancer vaccines: moving beyond current paradigms. Clin. Cancer Res. 13, 3776–3782 (2007).
    Article CAS Google Scholar
  21. Gattinoni, L., Powell, D.J., Jr., Rosenberg, S.A. & Restifo, N.P. Adoptive immunotherapy for cancer: building on success. Nat. Rev. Immunol. 6, 383–393 (2006).
    Article CAS Google Scholar
  22. Huddleston, H.G., Wong, K.K., Welch, W.R., Berkowitz, R.S. & Mok, S.C. Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker. Gynecol. Oncol. 96, 77–83 (2005).
    Article CAS Google Scholar
  23. Marasciulo, F.L., Montagnani, M. & Potenza, M.A. Endothelin-1: the yin and yang on vascular function. Curr. Med. Chem. 13, 1655–1665 (2006).
    Article CAS Google Scholar
  24. Salani, D. et al. Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Am. J. Pathol. 157, 1703–1711 (2000).
    Article CAS Google Scholar
  25. Motte, S., McEntee, K. & Naeije, R. Endothelin receptor antagonists. Pharmacol. Ther. 110, 386–414 (2006).
    Article CAS Google Scholar
  26. Wanecek, M., Weitzberg, E., Rudehill, A. & Oldner, A. The endothelin system in septic and endotoxin shock. Eur. J. Pharmacol. 407, 1–15 (2000).
    Article CAS Google Scholar
  27. Sampaio, A.L., Rae, G.A. & Henriques, M.M. Role of endothelins on lymphocyte accumulation in allergic pleurisy. J. Leukoc. Biol. 67, 189–195 (2000).
    Article CAS Google Scholar
  28. Sampaio, A.L., Rae, G.A. & Henriques, M.G. Effects of endothelin ETA receptor antagonism on granulocyte and lymphocyte accumulation in LPS-induced inflammation. J. Leukoc. Biol. 76, 210–216 (2004).
    Article CAS Google Scholar
  29. Wulfing, P. et al. Expression of endothelin-1, endothelin-A, and endothelin-B receptor in human breast cancer and correlation with long-term follow-up. Clin. Cancer Res. 9, 4125–4131 (2003).
    PubMed Google Scholar
  30. Grimshaw, M.J. et al. A role for endothelin-2 and its receptors in breast tumor cell invasion. Cancer Res. 64, 2461–2468 (2004).
    Article CAS Google Scholar
  31. Kuhlmann, A., Amann, K., Schlotzer-Schrehardt, U., Kruse, F.E. & Cursiefen, C. Endothelin-1 and ETA-ETB receptor protein and mRNA: expression in normal and vascularized human corneas. Cornea 24, 837–844 (2005).
    Article Google Scholar
  32. Wagner, O.F. et al. Polar secretion of endothelin-1 by cultured endothelial cells. J. Biol. Chem. 267, 16066–16068 (1992).
    CAS PubMed Google Scholar
  33. Wedgwood, S. & Black, S.M. Endothelin-1 decreases endothelial NOS expression and activity through ETA receptor–mediated generation of hydrogen peroxide. Am. J. Physiol. Lung Cell. Mol. Physiol. 288, L480–L487 (2005).
    Article CAS Google Scholar
  34. Bagnall, A.J. et al. Deletion of endothelial cell endothelin B receptors does not affect blood pressure or sensitivity to salt. Hypertension 48, 286–293 (2006).
    Article CAS Google Scholar
  35. Halcox, J.P., Nour, K.R., Zalos, G. & Quyyumi, A.A. Endogenous endothelin in human coronary vascular function: differential contribution of endothelin receptor types A and B. Hypertension 49, 1134–1141 (2007).
    Article CAS Google Scholar
  36. Cardillo, C., Kilcoyne, C.M., Waclawiw, M., Cannon, R.O., III & Panza, J.A. Role of endothelin in the increased vascular tone of patients with essential hypertension. Hypertension 33, 753–758 (1999).
    Article CAS Google Scholar
  37. Kubes, P. Inducible nitric oxide synthase: a little bit of good in all of us. Gut 47, 6–9 (2000).
    Article CAS Google Scholar
  38. Gauthier, T.W., Davenpeck, K.L. & Lefer, A.M. Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in splanchnic ischemia-reperfusion. Am. J. Physiol. 267, G562–G568 (1994).
    CAS PubMed Google Scholar
  39. Lelamali, K., Wang, W., Gengaro, P., Edelstein, C. & Schrier, R.W. Effects of nitric oxide and peroxynitrite on endotoxin-induced leukocyte adhesion to endothelium. J. Cell. Physiol. 188, 337–342 (2001).
    Article CAS Google Scholar
  40. Cowburn, P.J. et al. Comparison of selective ETA and ETB receptor antagonists in patients with chronic heart failure. Eur. J. Heart Fail. 7, 37–42 (2005).
    Article CAS Google Scholar
  41. Baatz, H. & Pleyer, U. Modulation of leukocyte-endothelium interaction by nitric oxide synthase inhibitors: effects on leukocyte adhesion in endotoxin-induced uveitis. Inflamm. Res. 50, 534–543 (2001).
    Article CAS Google Scholar
  42. Hickey, M.J. Role of inducible nitric oxide synthase in the regulation of leucocyte recruitment. Clin. Sci. (Lond.) 100, 1–12 (2001).
    Article CAS Google Scholar
  43. Feuerer, M., Eulenburg, K., Loddenkemper, C., Hamann, A. & Huehn, J. Self-limitation of Th1-mediated inflammation by IFN-γ. J. Immunol. 176, 2857–2863 (2006).
    Article CAS Google Scholar
  44. Waldow, T., Witt, W., Weber, E. & Matschke, K. Nitric oxide donor–induced persistent inhibition of cell adhesion protein expression and NF-κB activation in endothelial cells. Nitric Oxide 15, 103–113 (2006).
    Article CAS Google Scholar
  45. Kelleher, Z.T., Matsumoto, A., Stamler, J.S. & Marshall, H.E. NOS2 regulation of NF-κB by _S_-nitrosylation of p65. J. Biol. Chem. 282, 30667–30672 (2007).
    Article CAS Google Scholar
  46. López, A. et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit. Care Med. 32, 21–30 (2004).
    Article Google Scholar
  47. Ng, Q.S. et al. Effect of nitric oxide synthesis on tumour blood volume and vascular activity: a phase 1 study. Lancet Oncol. 8, 111–118 (2007).
    Article CAS Google Scholar
  48. Iqbal, J., Sanghia, R. & Das, S.K. Endothelin receptor antagonists: an overview of their synthesis and structure-activity relationship. Mini Rev. Med. Chem. 5, 381–408 (2005).
    Article CAS Google Scholar
  49. Morris, C.D. et al. Specific inhibition of the endothelin A receptor with ZD4054: clinical and pre-clinical evidence. Br. J. Cancer 92, 2148–2152 (2005).
    Article CAS Google Scholar
  50. Conejo-Garcia, J.R. et al. Vascular leukocytes contribute to tumor vascularization. Blood 105, 679–681 (2005).
    Article CAS Google Scholar

Download references